365 related articles for article (PubMed ID: 9296705)
1. [Effect of novel derivatives of muramyl dipeptide on the immune system].
Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
[No Abstract] [Full Text] [Related]
2. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
3. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of immunomodulatory properties of muramyl peptides on immune system cells of young and old mice.
Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
Immunopharmacol Immunotoxicol; 1994 May; 16(2):149-63. PubMed ID: 8077604
[TBL] [Abstract][Full Text] [Related]
5. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
[No Abstract] [Full Text] [Related]
6. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
[No Abstract] [Full Text] [Related]
8. Modulation of natural killer activity by muramyl peptides: relationship with adjuvant and anti-infectious properties.
Le Garrec Y; Morin A
Nat Immun Cell Growth Regul; 1987; 6(2):65-76. PubMed ID: 2439906
[TBL] [Abstract][Full Text] [Related]
9. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
[TBL] [Abstract][Full Text] [Related]
10. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).
Phillips NC; Moras ML; Chedid L; Petit JF; Tenu JP; Lederer E; Bernard JM; Lefrancier P
J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756
[TBL] [Abstract][Full Text] [Related]
11. [The immunostimulating activity of muramyl dipeptide and its derivatives].
Karsonova MI; Andronova TM; Pinegin BV; Khaitov RM
Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):104-10. PubMed ID: 10852007
[No Abstract] [Full Text] [Related]
12. Behavioural effects of muramyl dipeptide and adamantylamide dipeptide in mice.
Sulcová A; Krsiak M; Masek K; Gulda O
Act Nerv Super (Praha); 1989 Jun; 31(2):127-9. PubMed ID: 2800947
[No Abstract] [Full Text] [Related]
13. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
[TBL] [Abstract][Full Text] [Related]
14. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
[TBL] [Abstract][Full Text] [Related]
15. Specific impaired alloreactivity of mice immunized with syngeneic MLCT-lymphoblasts using muramylpeptides as adjuvant.
Binz H; Tarcsay L; Wigzell H; Dukor P
Transplant Proc; 1981 Mar; 13(1 Pt 1):566-73. PubMed ID: 6455801
[No Abstract] [Full Text] [Related]
16. [Participation of the dopaminergic system in the immune response-stimulating effect of muramyl dipeptide].
Al'perina EL; Zidek Z; Idova GV; Devoĭno LV
Biull Eksp Biol Med; 1988 Aug; 106(8):198-200. PubMed ID: 3416056
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory activity of analog of muramyl dipeptide and their use as adjunct to chemotherapy of Leishmania donovani in hamster.
Puri A; Sahai R; Haq W; Zaidi A; Guru PY; Tripathi LM; Srivastava VM
Int Immunopharmacol; 2005 Jun; 5(6):937-46. PubMed ID: 15829410
[TBL] [Abstract][Full Text] [Related]
18. [Activation of cellular immunity in mice under normal conditions and in tumor growth during treatment with glucosaminyl muramyl dipeptide].
Pimenov AA; Rakhmilevich AL; Deev VV; Kirillova IV; Migdal TL; Andronova TM; Fuks BB
Vopr Med Khim; 1990; 36(1):58-60. PubMed ID: 2343578
[TBL] [Abstract][Full Text] [Related]
19. [Muramyl dipeptide derivatives in experimental and clinical use].
Kaliuzhin OV
Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):104-8. PubMed ID: 9532704
[No Abstract] [Full Text] [Related]
20. [Changes in purine metabolism in the macrophages of mice exposed to a new synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Tarakhovskiĭ AM; Andronova TM
Biull Eksp Biol Med; 1985 Jun; 99(6):685-7. PubMed ID: 2990603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
